Type 2 Diabetes Raises Mortality but Not Reoperation After Hip and Knee Replacement: Study

According to the study, type 2 diabetes was linked to a greater likelihood of death after both hip and knee replacement, while the risk of requiring additional surgery remained unchanged compared to patients without diabetes. Short-term adverse events, such as complications occurring soon after surgery, were only minimally affected. The researchers emphasize that other factors—including body mass index and the presence of additional health conditions—were more strongly associated with the need for reoperation and also influenced mortality risk. This suggests that while diabetes itself contributes to poorer survival, the interplay of obesity and comorbid illnesses may be equally or more important in determining surgical outcomes.

The authors conclude that careful preoperative assessment and long-term monitoring of patients with type 2 diabetes are essential to improve survival outcomes after joint replacement surgery. The findings highlight the importance of comprehensive patient management strategies that account for both metabolic disease and broader health status rather than focusing solely on surgical factors. As hip and knee replacement rates continue to rise worldwide, identifying and managing systemic risks in patients with diabetes will be key to maximizing the benefits of these common orthopedic procedures.

Keywords: Type 2 diabetes, hip replacement, knee replacement, mortality, reoperation, Swedish registry, BMJ Open